Bausch & Lomb (TSX:BLCO) Total Tax Payable : C$0 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Total Tax Payable?

Bausch & Lomb's Total Tax Payable for the quarter that ended in Mar. 2025 was C$0 Mil.

Bausch & Lomb's quarterly Total Tax Payable declined from Sep. 2024 (C$91 Mil) to Dec. 2024 (C$0 Mil) but then stayed the same from Dec. 2024 (C$0 Mil) to Mar. 2025 (C$0 Mil).

Bausch & Lomb Total Tax Payable Historical Data

The historical data trend for Bausch & Lomb's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Total Tax Payable Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

Bausch & Lomb Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Tax Payable	Get a 7-Day Free Trial														-	-	90.76	-	-

Bausch & Lomb Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Bausch & Lomb Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

BLCO:USA

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives